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Purpose: To perform a prospective analysis of the clinical outcomes of prophylactic anti-
biotic treatment before the standard surgical modality of living donor nephrectomy 
(LDN) without postoperative antibiotic treatment. 
Materials and Methods: From November 2005 to June 2010, a total of 470 patients un-
derwent LDN at our medical institution, and 280 of these patients were injected with 
1 g cephalosporin 30 minutes before the operation. The group receiving prophylactic 
antibiotics was compared with a control group composed of 190 patients who received 
injections of 2 g cephalosporin per day for 5 days after the operation. The presence of 
fever, incidence of blood transfusion, and period of drainage use were compared between 
the two groups. 
Results: There were no significant differences in gender, age, body mass index, in-
cidence of blood transfusion after the operation, fever over 38oC 3 days after the oper-
ation, or period of drain insertion between the single-dose group and the control group. 
The follow-up was conducted for 1 month after the operation, and 1 case of surgical site 
infection (SSI) was observed in each group (p=0.783).
Conclusions: Of 280 patients in the single-dose group, 1 contracted SSI. In comparison 
with the control group, which was dosed with prophylactic antibiotics for 5 days after 
the operation, the single-dose group did not have a significantly different occurrence 
of SSI. We found that the incidence rate of SSI did not increase, even though prophylactic 
antibiotics were not used after standard and conventional open surgeries, such as vid-
eo-assisted minilaparotomy surgery.
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INTRODUCTION
Surgical site infection (SSI) is the third most frequently re-
ported nosocomial infection [1]. SSI is defined as an in-
fection that occurs in the skin and soft tissue of a surgical 
site within 30 days after an operation. Any purulent dis-
charge from a closed surgical incision, together with signs 
of inflammation of the surrounding tissue, should be con-
sidered to be a wound infection, irrespective of whether mi-
croorganisms can be cultured [2].
SSIs are a significant source of postoperative morbidity; 
they result in longer hospital stays and increased cost. 
Kirkland et al found that surgical patients (of all special-
ties) with SSI were twice as likely to die, 60% more apt to 
be admitted to an intensive care unit, and greater than five 
times as likely to require hospital readmission [3].
In recent times, antibiotics have been advanced, thus im-
proving the treatment options for various bacterial 
diseases. Nevertheless, SSI is still an important problem, 
despite the prophylactic use of antibiotics; in particular, 
the overuse of antibiotics is a serious problem. Staphylococ-
cus aureus, i.e., the major pathogen of SSI, easily develops 
antibiotic resistance. In particular, methicillin-resistant 
S. aureus infection is an important social problem, owing 
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TABLE 1. Patient characteristics in living donor nephrectomy
Control group Single-dose group 
p-value
(n=190) (n=280)
Sex 
  Female  93 (48.95%) 157 (56.07%) 0.133
  Male  97 (51.05%) 123 (43.93%) 0.133
Age (yr)   39.74±11.35   40.93±10.68 0.246
BMI 23.86±3.36 23.42±2.88 0.130
DM 0   1 (0.36%) 0.318
HTN 11 (5.79%)   7 (2.50%) 0.091
BMI: body mass index, DM: diabetes mellitus, HTN: hyper-
tension
TABLE 2. Perioperative results comparing the control group and 
the single-dose group
Control group 
(n=190)
Single-dose 
group (n=280)
p-value
Blood transfusion (n, %)
POD3 fever over 
38oC (n, %)
Drainage insertion 
period (d)
Higher-age group, 
≥50 yr (n, %)
POD2 leukocytosis, 
＞10,000 cells/ul (n, %)
4 (2.11)
4 (2.11)
4.20 (1-11)
40 (21.05)
13 (6.84)
3 (1.07)
4 (1.43)
4.51 (1-15)
67 (23.92)
14 (5.00)
0.448
0.720
0.089
0.467
0.401
POD: postoperative day
to the difficulty of treatment and patients’ mental and 
physical anguish and financial burden [4,5].
Many recent studies have suggested that the post-
operative administration of antibiotics is not necessary to 
prevent SSI if a standardized surgical treatment has been 
performed [6]. Standardized techniques are widely used in 
urologic surgeries, but the prolonged administration of an-
tibiotics after an operation has not been fully studied [7].
At our institute, live donor nephrectomy (LDN) has been 
performed in accordance with the standardized video-as-
sisted minilaparotomy surgery (VAMS) technique. This 
study was prospectively performed to ascertain whether a 
single dose of prophylactic antibiotics is sufficient to pre-
vent SSI in patients who undergo LDN. 
MATERIALS AND METHODS
This study was conducted on 470 patients who underwent 
VAMS-LDN at our institution between November 2005 
and June 2010. The patients had not received any anti-
biotics before the operation and had no problems with im-
mune function. The experimental group included 280 pa-
tients who were injected with 1 g cephalosporin 30 minutes 
before the operation, and these patients were compared 
with a control group composed of 190 patients who were in-
jected with 2 g cephalosporin per day for 5 days after the 
operation.
Exclusion criteria included a history of allergic reaction 
to cephalosporin, age younger than 18 years or older than 
80 years, concurrent use of systemic antibiotics or prophy-
lactic antibiotics for a medical condition, extended anes-
thetic time due to cooperation with other departments, and 
inability to return for follow-up evaluation.
　We collected information about the patient’s character-
istics, including their past history of hypertension, dia-
betes mellitus, and blood transfusion, and a calculation was 
made to determine the length of catheterization (the drain 
[HemovacⓇ; Zimmer, Dover, OH, USA] and Foley cathe-
ter). Body temperature was checked every day during hos-
pitalization to identify cases in which it exceeded 38oC even 
3 days after the operation. During hospitalization (5 days) 
and 1 month after the operation, physical examination was 
used to determine whether the surgical site was infected.
For statistical analysis, SPSS ver. 12.0 (SPSS Inc., Chicago, 
IL, USA) was used. To compare intergroup variables, the 
Student's t-test and the chi-square test were used. The sig-
nificance level was set at a p-value of less than 0.05.
RESULTS
The 280 patients who were given the single dose of anti-
biotics (the single-dose group) were composed of 123 males 
(43.93%) and 157 females (56.07%), with an average age of 
40.93 years (range, 17-63 years). The control group of 190 
patients was composed of 97 males (51.05%) and 93 females 
(48.95%), with an average age of 39.74 years (range, 16-66 
years). The body mass index (BMI) was 23.42 and 23.86 in 
the single-dose group and the control group, respectively, 
and no significant inter-group difference was observed 
(p=0.130). There was only one patient with diabetes melli-
tus in the single-dose group (0.36%), and there was no sig-
nificant difference between the groups in the number of pa-
tients with hypertension (Table 1).
　In the control group, 4 patients (2.11%) received a blood 
transfusion after the operation, and in the single-dose 
group, 3 patients (1.07%) received a transfusion (p=0.448). 
Each group had 4 patients who had a fever over 38oC for 
3 days after the operation, but this was not statistically sig-
nificant (p=0.720). The period of drain insertion was 4.51 
days (range, 1-15 days) and 4.20 days (range, 1-11 days) in 
the single-dose group and the control group, respectively, 
but there was no significant intergroup difference (p= 
0.089) (Table 2).
　The follow-up was conducted for 1 month after the oper-
ation, during which time 1 case of wound infection was ob-
served at the superficial surgical site in each group 
(p=0.783).
DISCUSSION
SSI has been reported to account for 38% of all of pathogenic 
infections. To prevent pathogenic infection, prophylactic 
antibiotics have been used after operations [2]. There have 
been many cases in which prophylactic antibiotics were ad-
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ministered before the operation and were used until the 
drain was removed or the stitches removed. As surgical 
techniques have advanced, however, the operative time 
has been shortened, surgeries have become less invasive, 
and techniques have become standardized. As the case 
stands now, there is controversy about the postoperative 
use of prophylactic antibiotics [6,8].
　The guidelines established by the American Urological 
Association stipulate that, in operations for clean-con-
taminated wounds, prophylactic antibiotics should only be 
used when risk factors are observed [9]. The European 
Association of Urology guidelines stipulate that prophy-
lactic antibiotics are not to be used for cases in which lapa-
roscopic surgeries or open surgeries are free from con-
tamination, but, in clean-contaminated wounds, a single 
dose of prophylactic antibiotics needs to be given [10].
　Prophylactic antibiotics should be used for the shortest 
possible period. Inappropriate antibiotic use increases en-
vironmental pressures favoring the emergence of anti-
microbial-resistant bacteria that can cause SSI, resulting 
in an increase in the cost of health care [11]. In Korea, the 
use of antibiotics is hardly restricted, and antimicrobial- 
resistant bacteria, such as methicillin-resistant S. aureus, 
are more prevalent than in other countries. Methicillin-re-
sistant bacteria have increased since 1970, and in 1987, re-
sistant bacteria accounted for 55.6% of infections. In 2005, 
antimicrobial resistance was reported to have reached 70% 
[4,5].
Antibiotics themselves may cause side effects, such as 
nephrotoxicity, allergy, and even hemolytic anemia as a re-
sult of the production of drug-induced antibodies [12,13]. 
A rare but important complication of antibiotic use is pseu-
domembranous enterocolitis, which is induced most com-
monly by clindamycin, the cephalosporins, and ampicillin 
[14,15].
Due to these adverse effects, appropriate reduction of the 
use of antimicrobial prophylaxis should be considered.
In Korea, there have been few well-designed prospective 
studies on the prophylactic use of antibiotics for urologic 
surgeries, and as a result, prophylactic antibiotics are often 
inappropriately used in a variety of urologic surgical proce-
dures [7,16].
　SSI occurs when bacteria are resistant to antibiotics or 
the surgical site is exposed to innumerable bacteria, most 
of which are introduced by the operators’ contaminated 
hands [17-21]. Thus, laparoscopic surgeries and mini-
mal-incision surgeries lower the possibility of occurrence, 
because they are performed mostly by the use of instru-
ments instead of surgeons’ hands [22,23].
Yoshida et al, who performed minimum-incision endo-
scopic surgeries for adrenal and renal tumors, reported 
that superficial SSI occurred in 1 of 31 in a group that re-
ceived a single dose of prophylactic antibiotics 30 minutes 
before the operation, but there were no cases of deep surgi-
cal sites or distant regions being infected [6].
With regard to this study, SSI occurred in one patient 
from each group, and no significant intergroup differences 
were observed (p=0.783). Our results suggest that LDN, 
which technically is a well-standardized surgery, does not 
require the use of postoperative prophylactic antibiotics, 
thus minimizing the risks of adverse effects and the prob-
able development of a new resistant bacterium. 
　Furthermore, our study could provide basic data for es-
tablishing Korean guidelines for antibiotic prophylaxis in 
urology.
　The present study had some limitations. The study was 
conducted on comparatively healthy patients, who are not 
at high risk for infection. Therefore, on the basis of our 
study results, we cannot ascertain whether the prophy-
lactic single dose is sufficient for high-risk groups. Conse-
quently, there is a need to perform further studies on 
high-risk groups.
CONCLUSIONS
Of 280 patients who received a single dose of prophylactic 
antibiotics before the operation, 1 patient contracted an 
SSI. In comparison with the control group, which received 
prophylactic antibiotics for 5 days after the operation, the 
single-dose group did not show a significant difference in 
the occurrence of SSI. In conclusion, we found that the in-
cidence rate of SSI did not increase when prophylactic anti-
biotics were not used after VAMS, a standard, conventional 
open surgery.
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